Survival and Glycemic Control in Patients With Colorectal Cancer and Diabetes Mellitus

Authors:

Abstract
Aim: The impact of diabetes mellitus (DM) on survival in patients with colorectal cancer and the impact of colorectal cancer on glycemic control were examined. Materials & methods: Patients with colorectal cancer with and without DM were matched 1:1 (2007–2015). Characteristics were compared between the two groups and survival assessed with the Kaplan–Meier method. Mixed models compared hemoglobin A1c and glucose levels over time. Results: In both groups, glucose values decreased during the year following cancer diagnosis (p < 0.001). 5-year overall survival was 56% (95% CI: 42–68%) for DM patients versus 57% (95% CI: 43–69%) for non-DM patients (p = 0.62). Conclusion: DM did not adversely impact survival of patients with colorectal cancer. Colorectal cancer did not affect glycemic control. Lay abstract The aim of this study was to evaluate the effect of diabetes mellitus (DM) on survival of patients with colorectal cancer and to determine whether colorectal cancer affected glycemic control. From an institutional cancer registry, 170 patients with colorectal cancer were identified and grouped by the presence (n = 85) or absence of DM (n = 85). The groups were matched by age and year of colorectal cancer diagnosis. DM did not decrease the survival and colorectal cancer did not significantly affect glucose levels of patients with DM.

This publication has 21 references indexed in Scilit: